DR. Shereef ElnahalThe President and CEO of the University Hospital in Newark, New Jersey, told CNBC on Monday that the majority of people in the nearby community would like to receive the Covid vaccine, a shift from the earlier date of its introduction.
“There is a considerable amount of hesitation, especially in color communities and urban communities like the one we operate in here in Newark,” said Elnahal, the state’s largest city “Worldwide exchange.” “The good news, however, is that hesitation is moving in the right direction.”
“We only had about 40% of the city of Newark and the surrounding area ready and ready to take the vaccine on arrival. Now that number is closer to 60%,” added Elnahal former New Jersey health commissioner under the Democratic Governor Phil Murphy.
Elnahal’s comments come as Covid vaccine adoption accelerates in the US.
On Saturday a A record 2.9 million doses were administeredaccording to the Centers for Disease Control and Prevention. In total, more than 90 million doses of Covid were administered.
Johnson & JohnsonThe single vaccine was approved as the third emergency vaccine by the US Food and Drug Administration on February 27.
The CDC vaccine tracker numbers don’t yet explicitly state how many recordings were made by J&J, as they were only launched in the US last week.
While the pace of vaccination has increased and eligibility has increased over the past few weeks, some health professionals, such as former FDA Commissioner Dr. Scott Gottlieb, have warned that the pool of Americans is eager to receive the shot could dry out sooner than expected.
“I think the demand here … is deep, but not great,” Gottlieb, a Pfizer board member, told CNBC last month. “There are probably about 100 million Americans who want this very badly. We also have to work on it.”
Shortly after the FDA approved Pfizer’s emergency vaccine, some hospital directors speculated that they were hesitant even among their staff would fade over time as skeptical employees, their colleagues saw the shots received.
Indeed, the US public’s desire to be vaccinated against Covid has increased in recent months. According to a poll from the Pew Research Center As of the beginning of this month, 69% plan to receive or have already received a Covid vaccine. This is an improvement on Pew’s results in November – a month before Pfizer or Moderna officially received FDA approval – that only 60% of Americans intended to be vaccinated.
Survey have shown Blacks and Latinos are more skeptical about vaccines than the US as a whole due to historical abuse in medicine. Racial differences also in vaccine distribution were observed in the USA
Elnahal said University Hospital – a teaching hospital for the Rutgers New Jersey Medical School – Has run various outreach programs to increase confidence in Covid vaccines.
“When we walk through that door of trust and finally say, ‘Hey, we are here with an initiative that may save your life,’ especially in a community that has been hit so hard,” Elnahal said, “we emphasize that Also, all three of these vaccines prevent 100% hospitalization and death [from Covid]. “
“That’s huge, and frankly these vaccines are better than so many others that have been around for a long time,” he added.
Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, healthcare technology company Aetion and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings‘ and royal caribbean“Healthy Sail Panel”.